Pancreatic Cancer Research

ResearcherUC San Diego Health SystemActive in the last 2 years

Jorge de la Torre Medina

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4701-8438; OpenAlex author ID A5102684769. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and the CD155/TIGIT Pathway. Co-author DOI 10.1158/1535-7163.mct-25-0129↗
  2. Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment. Co-author DOI 10.1158/1535-7163.mct-23-0572↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Chen · 2 shared papers, 2024–2026 · strength 0.46
  2. Rebekah Ruth White · 2 shared papers, 2024–2026 · strength 0.46
  3. Jayanth S. Shankara Narayanan · 1 shared paper, 2024 · strength 0.19
  4. Suna Erdem · 1 shared paper, 2024 · strength 0.19
  5. Andrew M. Lowy · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.